Rosario, Argentina Clinical Trials

A listing of Rosario, Argentina clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 134 clinical trials
Ulnar Wrist Pain Treatment With Dextrose Prolotherapy

Participants who have failed therapy for chronic wrist pain on the little finger side of the wrist will recieve dextrose prolotherapy. Their results will be compared to a cohort of consecutive participants who have not failed therapy, and receive 4 weeks of usual care.

Scanner Centro de Diagnostico
 (2.2 away) Contact site
  • 0 views
  • 11 May, 2021
  • 1 location
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

This is a Phase 3, open-label, multicenter extension study to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

remission
crohn's disease
Instituto Medico de la Fundacion Estudios Clinicos
 (0.2 away) Contact site
  • 1032 views
  • 22 Feb, 2021
  • +807 other locations
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.

remission
abdominal pain
crohn's disease
Instituto Medico de la Fundacion Estudios Clinicos
 (0.2 away) Contact site
  • 858 views
  • 23 Feb, 2021
  • +780 other locations
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II IIIA and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

This trial will evaluate the safety and efficacy of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant chemotherapy (NAC) before surgery [neoadjuvant phase], followed by pembrolizumab alone after surgery [adjuvant phase] in participants with resectable stage II, IIIA, and resectable IIIB (T3-4N2) non-small cell lung cancer (NSCLC). The primary hypotheses …

mk-3475
lung carcinoma
pemetrexed
platinum doublet
solid tumour
Hospital Provincial del Centenario ( Site 0131)
 (2.6 away) Contact site
  • 551 views
  • 09 Jun, 2021
  • +237 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
Hopital Centenario /ID# 170898
 (0.2 away) Contact site
  • 604 views
  • 11 Jun, 2021
  • +772 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

stroke
stemi
arterial disease
diabetes
acute coronary syndrome
0320071 - Hospital Provincial del Centenario
 (1.2 away) Contact site
  • 1118 views
  • 09 Jun, 2021
  • +3422 other locations
Safety Tolerability and Efficacy of Rapid Optimization Helped by NT-proBNP testinG of Heart Failure Therapies

STRONG-HF is a multicenter, randomized, parallel group study designed to evaluate the efficacy and safety of up-titration of standard oral heart failure medications during hospitalization for acute heart failure. Patients admitted for acute heart failure will be randomized within 2 days before discharge to either usual care or intensification of …

angiotensin
dyspnea
nt-probnp
edema
acute heart failure
Rosario Clinical Research Institute - Delta
 (2.6 away) Contact site
  • 119 views
  • 18 Feb, 2021
  • +157 other locations
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

ileal disease
crohn's disease
abdominal pain
immunomodulators
endoscopy
Instituto Medico de la Fundacion Estudios Clinicos
 (1.9 away) Contact site
  • 865 views
  • 09 Mar, 2021
  • +420 other locations
A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation

This is a randomized, double-blind, placebo-controlled study in patients with dilated cardiomyopathy (DCM) due to a mutation of the gene encoding the lamin A/C protein (LMNA). The study will further evaluate a dose level of study drug (ARRY-371797) that has shown preliminary efficacy and safety in this patient population. After …

walk test
implantable cardioverter-defibrillators
implantable cardioverter defibrillator
cardiac resynchronization therapy
arry-371797
Instituto CAICI
 (1.2 away) Contact site
  • 413 views
  • 24 May, 2021
  • +258 other locations
A Study to Determine the Efficacy Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) Versus Meropenem (MER) Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.

A Phase 3 comparative study to determine the efficacy, safety and tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) versus Meropenem (MER) Colistin (COL) for the treatment of serious infections due to Gram negative bacteria.

colistin
meropenem
antibiotics
antibiotic therapy
ATM
Sanatorio Britanico
 (2.6 away) Contact site
  • 185 views
  • 30 May, 2021
  • +181 other locations